April 3, 2018 / 10:21 AM / 6 months ago

BRIEF-‍TFF Pharma Says Closed Offering Of Series A Preferred Stock For Gross Proceeds Of $14 Mln​

April 3 (Reuters) - ‍TFF Pharmaceuticals:

* ‍TFF PHARMACEUTICALS SAYS CLOSED OFFERING OF SERIES A PREFERRED STOCK FOR GROSS PROCEEDS OF $14 MILLION​ Source text for Eikon:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below